References

cardio

Кардиология

Kardiologiia

0022-90402412-5660

Kardiomag

10.18087/cardio.2442

cardio-233

Research Article

ОБЗОРЫ

REVIEWS

Клеточная терапия хронической сердечной недостаточности - современное состояние проблемы

Cell therapy of chronic heart failure. State of the art

Белый

С. А.

Beliy

S. A.

noemail@neicon.ru

Комок

В. В.

Komok

V. V.

noemail@neicon.ru

ФГБОУ ВО «ПСПбГМУ им. акад. И.П. Павлова» МЗ РФРоссияAcademician Pavlov First St. Petersburg State Medical UniversityRussian Federation

2018

18112018

584S4654

2018

Kardiomag

https://cardio.elpub.ru/jour/about/submissions#copyrightNotice

https://cardio.elpub.ru/jour/article/view/233

Использование аутологичной мононуклеарной фракции костного мозга (или ее производных) для лечения пациентов с ХСН -перспективный метод лечения этой тяжелой и многочисленной группы больных. Анализируются зарубежный и отечественный опыт использования клеточной терапии для лечения больных ХСН и возможность широкого использования аутологичной мононуклеарной фракции костного мозга в клинической практике.

The treatment of patients with CHF using autologous bone marrow-derived mononuclear cell fraction (or its derivatives) is a promising therapy for this serious and numerous group of patients. The article analyzed international and Russian experience of using the cell therapy in patients with CHF and possibilities for extensive use of the autologous bone marrow-derived mononuclear cell fraction in clinical practice.

клеточная терапияаутологичная мононуклеарная фракция костного мозгаХСНcell therapyautologous bone marrow-derived mononuclear cell fractionchronic heart failure

References1

Cook C., Cole G., Asaria P., Jabbour R., Francis D.P. The annual global economic burden of heart failure. International Journal of Cardiology. 2014; 171 (3): 368-76. DOI: 10.1016/j.ijcard.2013.12.028

Mozaffarian D., Benjamin E.J., Go A.S., Arnett D.K., Blaha M.J., Cushman M. et al. Heart Disease and Stroke Statistics - 2016 Update: A Report From the American Heart Association. Circulation. 2016; 133(4): e38-360.DOI: 10.1161/CIR.0000000000000350

Jessup M. The Heart Failure Paradox: An Epidemic of Scientific Success: Presidential Address at the American Heart Association 2013 Scientific Sessions. Circulation. 2014; 129 (25): 2717-22. DOI: 10.1161/CIR.0000000000000065

Frangogiannis N.G. Pathophysiology of Myocardial Infarction. Terjung R, редактор. Comprehensive Physiology [Интернет]. -Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2015сен20 [цитируется по 10 апрель 2018 г.]. с. 1841-75. ISBN: 978-0-470-65071-4

Jennings R.B. Historical Perspective on the Pathology of Myocardial Ischemia/Reperfusion Injury. Circulation Research. 2013; 113 (4): 428-38. DOI: 10.1161/CIRCRESAHA.113.300987

Bergmann O., Bhardwaj R.D., Bernard S., Zdunek S., Barnabé-Heider F., Walsh S. et al. Evidence for Cardiomyocyte Renewal in Humans. Science. 2009; 324 (5923): 98-102. DOI: 10.1126/science.1164680

Senyo S.E., Steinhauser M.L., Pizzimenti C.L., Yang V.K., Cai L., Wang M. et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature. 2012,493 (7432): 433-6. DOI: 10.1038/nature11682

Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990, 81 (4): 1161-72. PMID: 2138525

Chan W., Duffy S.J., White D.A., Gao X.-M., Du X.-J., Ellims A.H. et al. Acute Left Ventricular Remodeling Following Myocardial Infarction. JACC: Cardiovascular Imaging. 2012,5 (9): 884-93. DOI: 10.1016/j.jcmg.2012.03.015

Burchfield J.S., Xie M., Hill J.A. Pathological Ventricular Remodeling: Mechanisms: Part 1 of 2. Circulation. 2013, 128 (4): 388-400. DOI: 10.1161/CIRCULATIONAHA.113.001878

Xie M., Burchfield J.S., Hill J.A. Pathological Ventricular Remodeling: Therapies: Part 2 of 2. Circulation. 2013, 128 (9): 1021-30. DOI: 10.1161/CIRCULATIONAHA.113.001879

Jugdutt B.I. Ventricular Remodeling After Infarction and the Extracellular Collagen Matrix: When Is Enough Enough? Circulation. 2003, 108 (11): 1395-403. DOI: 10.1161/01.CIR.0000085658.98621.49

Wilcox J.E., Fonarow G.C., Ardehali H., Bonow R.O., Butler J., Sauer A.J. et al. «Targeting the Heart» in Heart Failure. JACC: Heart Failure. 2015,3 (9): 661-9. DOI: 10.1016/j.jchf.2015.04.011

Tseng C.C.S., Ramjankhan F.Z., de Jonge N., Chamuleau S.A.J. Advanced Strategies for End-Stage Heart Failure: Combining Regenerative Approaches with LVAD, a New Horizon? Frontiers in Surgery [Интернет]. 2015 [цитируется по 10 апрель 2018 г.], 2. DOI: 10.3389/fsurg.2015.00010

Gheorghiade M., Larson C.J., Shah S.J., Greene S.J., Cleland J.G.F., Colucci W.S. et al. Developing New Treatments for Heart Failure: Focus on the Heart. Circulation: Heart Failure. 2016,9 (5): e002727. DOI: 10.1161/CIRCHEARTFAILURE.115.002727

Braunwald E. Research Advances in Heart Failure: A Compendium. Circulation Research. 2013,113 (6): 633-45. DOI: 10.1161/CIRCRESAHA.113.302254

Pompilio G., Nigro P., Bassetti B., Capogrossi M.C. Bone Marrow Cell Therapy for Ischemic Heart Disease: Figure.: The Never Ending Story. Circulation Research. 2015, 117 (6): 490-3. DOI: 10.1161/CIRCRESAHA. 115.307184

Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B. et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001,410 (6829): 701-5. DOI: 10.1038/35070587

Orlic D., Kajstura J., Chimenti S., Bodine D.M., Leri A., Anversa P. Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant. 2003, 7 Suppl 3: 86-8. PMID: 12603699

Kubal C., Sheth K., Nadal-Ginard B., Galinanes M. Bone marrow cells have a potent anti-ischemic effect against myocardial cell death in humans. The Journal of Thoracic and Cardiovascular Surgery. 2006, 132 (5): 1112-8. DOI: 10.1016/j.jtcvs.2006.06.028

Duran J.M., Makarewich C.A., Sharp T.E., Starosta T., Zhu F., Hoffman N.E. et al. Bone-Derived Stem Cells Repair the Heart After Myocardial Infarction Through Transdifferentiation and Paracrine Signaling Mechanisms. Circulation Research. 2013,113 (5): 539-52. DOI: 10.1161/CIRCRESAHA.113.301202

Protti A., Mongue-Din H., Mylonas K.J., Sirker A., Sag C.M., Swim M.M. et al. Bone marrow transplantation modulates tissue macrophage phenotype and enhances cardiac recovery after subsequent acute myocardial infarction. Journal of Molecular and Cellular Cardiology. 2016, 90: 120-8. DOI: 10.1016/j.yjmcc.2015.12.007

Karantalis V., Balkan W., Schulman I.H., Hatzistergos K.E., Hare J.M. Cell-based therapy for prevention and reversal of myocardial remodeling. American Journal of Physiology-Heart and Circulatory Physiology. 2012,303 (3): H256-70. DOI: 10.1152/ajpheart.00221.2012

Nahrendorf M., Pittet M.J., Swirski F.K. Monocytes: Protagonists of Infarct Inflammation and Repair After Myocardial Infarction. Circulation. 2010, 121 (22): 2437-45. DOI: 10.1161/CIRCULATIONAHA.109.916346

Ben-Mordechai T., Holbova R., Landa-Rouben N., Harel-Adar T., Feinberg M.S., Abd Elrahman I. et al. Macrophage Subpopulations Are Essential for Infarct Repair With and Without Stem Cell Therapy. Journal of the American College of Cardiology. 2013,62 (20): 1890-901. DOI: 10.1016/j.jacc.2013.07.057

Wynn T.A., Vannella K.M. Macrophages in Tissue Repair, Regeneration, and Fibrosis. Immunity. 2016,44 (3): 450-62. DOI: 10.1016/j.immuni. 2016.02.015

Cheng K., Wu F., Cao F. Intramyocardial Autologous Cell Engraftment in Patients with Ischaemic Heart Failure: A Meta-Analysis of Randomised Controlled Trials. Heart, Lung and Circulation. 2013, 22 (11): 887-94. DOI: 10.1016/j.hlc.2013.04.112

Donndorf P., Kundt G., Kaminski A., Yerebakan C., Liebold A., Steinhoff G. et al. Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: A meta-analysis. The Journal of Thoracic and Cardiovascular Surgery. 2011,142 (4): 911-20. DOI: 10.1016/j.jtcvs.2010.12.013

Fisher S.A., Brunskill S.J., Doree C., Mathur A., Taggart D.P., Martin-Rendon E. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. The Cochrane Collaboration, редактор. Cochrane Database of Systematic Reviews [Интернет]. -Chichester, UK: John Wiley & Sons, Ltd, 2014апр29 [цитируется по 10 апрель 2018 г.].

Jeevanantham V., Butler M., Saad A., Abdel-Latif A., Zuba-Surma E.K., Dawn B. Adult Bone Marrow Cell Therapy Improves Survival and Induces Long-Term Improvement in Cardiac Parameters: A Systematic Review and Meta-Analysis. Circulation. 2012, 126 (5): 551-68. DOI: 10.1161/CIRCULATIONAHA. =111.086074

Jiang M., He B., Zhang Q., Ge H., Zang M.H., Han Z.H. et al. Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: meta-analysis. Expert Opinion on Biological Therapy. 2010,10 (5): 667-80. DOI: 10.1517/14712591003716437

Kandala J., Upadhyay G.A., Pokushalov E., Wu S., Drachman D.E., Singh J.P. Meta-Analysis of Stem Cell Therapy in Chronic Ischemic Cardiomyopathy. The American Journal of Cardiology. 2013,112 (2): 217-25. DOI: 10.1016/j.amjcard.2013.03.021

Sadat K., Ather S., Aljaroudi W., Heo J., Iskandrian A.E., Hage F.G. The effect of bone marrow mononuclear stem cell therapy on left ventricular function and myocardial perfusion. Journal of Nuclear Cardiology. 2014, 21 (2): 351-67. DOI: 10.1007/s12350-013-9846-4

Tian T, Chen B., Xiao Y., Yang K., Zhou X. Intramyocardial autologous bone marrow cell transplantation for ischemic heart disease: A systematic review and meta-analysis of randomized controlled trials. Atherosclerosis. 2014, 233 (2): 485-92. DOI: 10.1016/j.atherosclerosis.2014.01.027

Wen Y., Meng L., Xie J., Ouyang J. Direct autologous bone marrow-derived stem cell transplantation for ischemic heart disease: a meta-analysis. Expert Opinion on Biological Therapy. 2011,11 (5): 559-67. DOI: 10.1517/14712598.2011.560567

Xu R., Ding S., Zhao Y., Pu J., He B. Autologous Transplantation of Bone Marrow/Blood-Derived Cells for Chronic Ischemic Heart Disease: A Systematic Review and Meta-analysis. Canadian Journal of Cardiology. 2014,30 (11): 1370-7. DOI: 10.1016/j.cjca.2014.01.013

Zhao Q., Ye X. Additive value of adult bone-marrow-derived cell transplantation to conventional revascularization in chronic ischemic heart disease: a systemic review and meta-analysis. Expert Opinion on Biological Therapy. 2011, 11 (12): 1569-79. DOI: 10.1517/14712598.20 11.616491

Fisher S.A., Doree C., Mathur A., Martin-Rendon E. Meta-Analysis of Cell Therapy Trials for Patients With Heart Failure. Circulation Research. 2015, 116 (8): 1361-77. DOI: 10.1161/CIRCRESAHA.116.304386

Afzal M.R., Samanta A., Shah Z.I., Jeevanantham V., Abdel-Lati A., Zuba-Surma E.K. et al. Adult Bone Marrow Cell Therapy for Ischemic Heart DiseaseNovelty and Significance: Evidence and Insights From Randomized Controlled Trials. Circulation Research. 2015,117 (6): 558-75. DOI: 10.1161/CIRCRESAHA.114.304792

Fisher S.A., Doree C., Mathur A., Taggart D.P., Martin-Rendon E. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Heart Group, редактор. Cochrane Database of Systematic Reviews [Интернет]. 2016 [цитируется по 10 апрель 2018 г.], DOI: 10.1002/14651858.CD007888. pub3

Martin-Rendon E. Meta-Analyses of Human Cell-Based Cardiac Regeneration Therapies Response to Martin-Rendon: What Can Systematic Reviews Tell Us About Cell Therapies for Ischemic Heart Disease? Circulation Research. 2016; 118 (8): 1264-72. DOI: 10.1161/CIRCRESAHA.115.307540

Pokushalov E., Romanov A., Chernyavsky A., Larionov P., Terekhov I., Artyomenko S. et al. Efficiency ofIntramyocardial Injections ofAutolo-gous Bone Marrow Mononuclear Cells in Patients with Ischemic Heart Failure: A Randomized Study. Journal of Cardiovascular Translational Research. 2010; 3 (2): 160-8. DOI: 10.1007/s12265-009-9123-8

Чернявский А.М., Кливер Е.Н., Покушалов Е.А., Романов А.Б., Терехов И.Н., Кливер Е.Э. Результаты Интрамиокардиального Введения Мононуклеарной Фракции Аутологичных Клеток Костного Мозга Пациентам С. Ишемической Болезнью Сердца, Осложненной Сердечной Недостаточностью. Вестник Трансплантологии И. Искусственных Органов. 2013; 15 (3): 83-91.

Чернявский А.М., Кливер Е.Н., Покушалов Е.А., Кливер Е.Э., Романов А.Б. Отдаленные результаты клеточной терапии ИБС, осложненной С.Н. Сердце: Журнал Для Практикующих Врачей. 2015; 14 (1): 19-24.

Кливер Е.Н., Чернявский А.М., Покушалов Е.А., Кливер Е.Э., Романов А.Б., Субботин Д.В. Трехгодовые Результаты Трансэндокардиального Введения Мононуклеарной Фракции Аутологичных Клеток Костного Мозга Пациентам С. Ишемической Болезнью Сердца, Осложненной Сердечной Недостаточностью. Вестник Новосибирского Государственного Университета Серия: Биология, Клиническая Медицина. 2014; 12 (4): 38-43.

Комок В.В., Белый С.А., Гриненко О.А., Немков А.С. Клеточные технологии в комбинированном лечении ИБС. Практическая Медицина. 2015; (3-2 (88)): 10-6.

Нестерук Ю.А., Немков А.С., Белый С.А., Рыжкова Д.В., Комок В.В. Оценка динамики кровоснабжения и метаболизма миокарда после интракоронарного введения аутологичных мононуклеаров костного мозга. Регионарное Кровообращение И. Микроциркуляция. 2014; 13 (3 (51)): 23-30.

Седов В.М., Немков А.С., Белый С.А., Юдина О.В., Бурнос С.Н., Немков А.С. Изменение показателей перфузии миокарда после интракоронарного введения аутологичных мононуклеарных клеток костного мозга больным ИБС. Пятилетнее наблюдение. Регионарное Кровообращение И. Микроциркуляция. 2011; 10 (2): 19-23.

Бурнос С.Н., Немков А.С., Белый С.А., Лукашенко В.И. Фракция Выброса И. Размеры Левого Желудочка Сердца После Интракоронарного Введения Аутологичных Мононуклеарных Клеток Костного Мозга У. Больных С. Ишемической Болезнью Сердца Со Сниженной Фракцией Выброса. Вестник Хирургии Им Ии Грекова. 2011; 170 (4): 16-9.

Седов В.М., Немков А.С., Афанасьев Б.В., Белый С.А., Зверев О.Г., Бабенко Е.В. и др. Отдалённые Результаты Клинического Применения Аутологичной Мононуклеарной Фракции Костного Мозга Для Регенеративной Терапии Больных С. Ишемической Болезнью Сердца. Вестник Хирургии Им И.И. Грекова. 2012; 171 (5): 11-9.

Немков А.С., Белый С.А., Нестерук Ю.А., Бурнос С.Н., Лукашенко В.И., Крейль В.А. и др. Качество Жизни У. Больных С. Ишемической Болезнью Сердца После Применения Клеточной Терапии. Вестник Хирургии Им ИИ Грекова. 2012; 171 (1): 16-20.

Немков А.С., Белый С.А., Комок В.В., Атмадзас К.А., Филатов В.И., Рыжкова Д.В. Имплантация Аутологичных Мононуклеаров Костного Мозга Как Первый Этап Комплексного Хирургического Лечения Ишемической Болезни Сердца В. Сочетании С. Аортокоронарным Шунтированием. Вестник Хирургии Им И.И. Грекова. 2015; 174 (6): 85-8.

Carson P., Wertheimer J., Miller A., O»Connor C.M., Pina I.L., Selzman C. et al. The STICH Trial (Surgical Treatment for Ischemic Heart Failure). JACC: Heart Failure. 2013; 1 (5): 400-8. DOI: 10.1016/j.jchf.2013.04.012

Petrie M.C., Jhund P.S., She L., Adlbrecht C., Doenst T., Panza J.A. et al. Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction Clinical Perspective: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure). Circulation. 2016; 134 (18): 1314-24. DOI: 10.1161/CIR-CULATIONAHA.116.024800

Briceno N., Perera D. To Revascularise or Not To Revascularise, That Is the Question: the Diagnostic and Management Conundrum of Ischaemic Cardiomyopathy. Current Cardiology Reports [Интернет]. 2016 [цитируется по 11 апрель 2018 г.]; 18 (6). DOI: 10.1007/s11886-016-0726-9

Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K. et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell. 2007; 131 (5): 861-72. DOI: 10.1016/j.cell. 2007.11.019

Miyazaki S., Yamamoto H., Miyoshi N., Takahashi H., Suzuki Y., Haraguchi N. et al. Emerging Methods for Preparing iPS Cells. Japanese Journal of Clinical Oncology. 2012; 42 (9): 773-9. DOI: 10.1093/jjco/hys108

Beltrami A.P., Urbanek K., Kajstura J., Yan S.-M., Finato N., Bussani R. et al. Evidence That Human Cardiac Myocytes Divide after Myocardial Infarction. New England Journal of Medicine. 2001; 344 (23): 1750-7. DOI: 10.1056/NEJM200106073442303

Anversa P., Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature. 2002; 415 (6868): 240-3. DOI: 10.1038/415240a

Nadal-Ginard B., Kajstura J., Leri A., Anversa P. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res. 2003; 92 (2): 139-50. PMID: 12574141

Hsieh P.C.H., Segers V.F.M., Davis M.E., MacGillivray C., Gannon J., Molkentin J.D. et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nature Medicine. 2007; 13 (8): 970-4. DOI: 10.1038/nm1618

Bergmann O., Zdunek S., Felker A., Salehpour M., Alkass K., Bernard S. et al. Dynamics of Cell Generation and Turnover in the Human Heart. Cell. 2015; 161 (7): 1566-75. DOI: 10.1016/j.cell.2015.05.026

Loffredo F.S., Steinhauser M.L., Gannon J., Lee R.T. Bone Marrow-Derived Cell Therapy Stimulates Endogenous Cardiomyocyte Progenitors and Promotes Cardiac Repair. Cell Stem Cell. 2011; 8 (4): 389- 78. 98. DOI: 10.1016/j.stem.2011.02.002

Keith M.C.L., Bolli R. «String Theory» of c-kit (pos) Cardiac Cells: A New Paradigm Regarding the Nature of These Cells That May Reconcile Apparently Discrepant Results. Circulation Research. 2015; 116 (7): 1216-30. DOI: 10.1161/CIRCRESAHA.116.305557

Malliaras K., Terrovitis J. Cardiomyocyte proliferation vs progenitor cells in myocardial regeneration: The debate continues. Global Cardiology Science and Practice. 2013; 2013 (3): 37. DOI: 10.5339/gcsp.2013.37

Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nature Reviews Molecular Cell Biology. 81. 2006; 7 (8): 589-600. DOI: 10.1038/nrm1983

Eschenhagen T., Bolli R., Braun T., Field L.J., Fleischmann B.K., Frisén J. et al. Cardiomyocyte Regeneration: A Consensus Statement. Circulation. 2017; 136 (7): 680-6. DOI: 10.1161/CIRCULATIONAHA.82.117.029343

van Berlo J.H., Kanisicak O., Maillet M., Vagnozzi R.J., Karch J., Lin S.-C.J. et al. c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature. 2014; 509 (7500): 337-41. DOI: 10.1038/nature13309

Molkentin J.D., Houser S.R. Are Resident c-kit+ Cardiac Stem Cells Really All That Are Needed to Mend a Broken Heart? Circulation Research. 2013; 113 (9): 1037-9. DOI: 10.1161/CIRCRESAHA.113.302564

Nadal-Ginard B., Ellison G.M., Torella D. Absence of Evidence Is Not Evidence of Absence: Pitfalls of Cre Knock-Ins in the c-Kit Locus. Circulation Research. 2014; 115 (4): 415-8. DOI: 10.1161/CIRCRESAHA.114.304676

Bersell K., Arab S., Haring B., Kühn B. Neuregulin1/ErbB4 Signaling Induces Cardiomyocyte Proliferation and Repair of Heart Injury. Cell. 2009; 138 (2): 257-70. DOI: 10.1016/j.cell.2009.04.060

Kühn B., del Monte F., Hajjar R.J., Chang Y.-S., Lebeche D., Arab S. et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nature Medicine. 2007; 13 (8): 962-9. DOI: 10.1038/nm1619

Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S. et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003; 114 (6): 763-76. PMID: 14505575

Messina E. Isolation and Expansion ofAdult Cardiac Stem Cells From Human and Murine Heart. Circulation Research. 2004; 95 (9): 911-21. DOI: 10.1161/01.RES. 0000147315.71699.51

Nadal-Ginard B., Ellison G.M., Torella D. "The cardiac stem cell compartment is indispensable for myocardial cell homeostasis, repair and regeneration in the adult. Stem Cell Research. 2014; 13 (3): 615-30. DOI: 10.1016/j.scr.2014.04.008

Ellison G.M., Vicinanza C., Smith A.J., Aquila I., Leone A., Waring C.D. et al. Adult c-kitpos Cardiac Stem Cells Are Necessary and Sufficient for Functional Cardiac Regeneration and Repair. Cell. 2013; 154 (4): 827-42. DOI: 10.1016/j. cell. 2013.07.039

Vicinanza C., Aquila I., Scalise M., Cristiano F., Marino F., Cianflone E. et al. Adult cardiac stem cells are multipotent and robustly myogenic: c-kit expression is necessary but not sufficient for their identification. Cell Death and Differentiation. 2017; 24 (12): 2101-16. DOI: 10.1038/cdd.2017.130

Torella D., Ellison G.M., Karakikes I., Nadal-Ginard B. Cardiovascular development: towards biomedical applicability: Resident cardiac stem cells. Cellular and Molecular Life Sciences. 2007; 64 (6): 661-73. DOI: 10.1007/s00018-007-6519-y

Rasmussen T.L., Raveendran G., Zhang J., Garry D.J. Getting to the Heart of Myocardial Stem Cells and Cell Therapy. Circulation. 2011; 123 (16): 1771-9. DOI: 10.1161/CIRCULATIONAHA. 109.858019

Leri A., Kajstura J., Anversa P. Role of Cardiac Stem Cells in Cardiac Pathophysiology: A Paradigm Shift in Human Myocardial Biology. Circulation Research. 2011; 109 (8): 941-61. DOI: 10.1161/CIR-CRESAHA.111.243154

Smith A.J., Lewis F.C., Aquila I., Waring C.D., Nocera A., Agosti V. et al. Isolation and characterization of resident endogenous c-kit+ cardiac stem cells from the adult mouse and rat heart. Nature Protocols. 2014; 9 (7): 1662-81. DOI: 10.1038/nprot. 2014.113

Miyamoto S., Kawaguchi N., Ellison G.M., Matsuoka R., Shin»oka T., Kurosawa H. Characterization of Long-Term Cultured c-kit + Cardiac Stem Cells Derived From Adult Rat Hearts. Stem Cells and Development. 2010; 19 (1): 105-16. DOI: 10.1089/scd.2009.0041

Hong K.U., Guo Y., Li Q.-H., Cao P., Al-Maqtari T., Vajravelu B.N. et al. c-kit+ Cardiac Stem Cells Alleviate Post-Myocardial Infarction Left Ventricular Dysfunction Despite Poor Engraftment and Negligible Retention in the Recipient Heart. Hare JM, редактор. PLoS ONE. 2014; 9(5): e96725. DOI: 10.1371/journal.pone.0096725

Kawaguchi N., Smith A.J., Waring C.D., Hasan M.K., Miyamoto S., Matsuoka R. et al. c-kitpos GATA-4 High Rat Cardiac Stem Cells Foster Adult Cardiomyocyte Survival through IGF-1 Paracrine Signalling. Hotchin NA, редактор. PLoS ONE. 2010; 5 (12): e14297. DOI: 10.1371/journal.pone.0014297

Ellison G.M., Torella D., Dellegrottaglie S., Perez-Martinez C., Perez de Prado A., Vicinanza C. et al. Endogenous Cardiac Stem Cell Activation by Insulin-Like Growth Factor-1/Hepatocyte Growth Factor Intracoronary Injection Fosters Survival and Regeneration of the Infarcted Pig Heart. Journal of the American College of Cardiology. 2011; 58 (9): 977-86. DOI: 10.1016/j.jacc. 2011.05.013

Bolli R., Chugh A.R., D»Amario D., Loughran J.H., Stoddard M.F., Ikram S. et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. The Lancet. 2011; 378 (9806): 1847-57. DOI: 10.1016/S0140-6736(11)61590-0

Makkar R.R., Smith R.R., Cheng K., Malliaras K., Thomson L.E., Berman D. et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. The Lancet. 2012; 379(9819): 895-904.

The authors declare that there are no conflicts of interest present.